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Genus Listeria:
L. monocytogenes
L. innocua
L. seeligeri
L. welshimeri
L. ivanovii
L. grayi
L. murrayi
Bacillus
Gram positive
Oxidase -
Catalase +
“Listeriosis”
Listeriosis
Is it a problem?
• Low incidence
• High severity (mortality rate > 30%)
• Dose of infection is still unknown
Risk groups for listeriosis:
Pregnant women
Newborns 
Persons with weakened immune systems 
Persons with cancer, diabetes, or kidney disease 
Persons with AIDS
The elderly 
Healthy adults and children occasionally get infected with Listeria, but 
they rarely become seriously ill. 
Epidemiology of
L. monocytogenes
Lethality  > 40% for the 24 
cases that it was know the 
progress of the infection 

Listeria monocytogenes in foods: 
contributing data for risk assessment
(PTDC/AGR-ALI/64662/2006)
Task 1: General characterization of L. monocytogenes strains 
isolated from different sources
(…)
Capacity to form biofilms 
(Cerca et al., 2004)
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Serovars
Typing the isolates 
of L. monocytogenes (n=1975)
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Food strains
Clinical strains
Percentage of food (n=258) and clinical isolates (n=118) for 
biofilm formation test
Conclusions
• In general, food strains have more capicity to 
form biofilms;
• At 37ºC, 4.2% of the clinical strains of L. 
monocytogenes were classified as strong 
biofilm producers against 0.39% of the food 
isolates;
• The biofilm production was temperature, strain 
and time dependent  
ISOPOL XVII will bring together specialists from a wide range of scientific disciplines from all over the world  -  
(from Vets, Medics, Bioscientists to Public-Health and Food Industry specialists, from junior researchers to  
world-leaders in their fields) Ğ to debate the most important and up to date issues concerning Listeria and Listeriosis.  
For the first time the ISOPOL will take place in Portugal in its second city and northern capital, Oporto. With its rich  
history, and unique atmosphere - at once ancient and contemporary - Oporto is becoming a major conference and  
destination and we promise that it will not disappoint for ISOPOL XVII. 
